跳至主要内容
临床试验/DRKS00032412
DRKS00032412尚未招募不适用

Evaluation of preoperative clinical and translational selection criteria for cytoreductive surgery in endometrial cancer - A retrospective multicenter trial with an accompanying translational project - STREAM-I

AGO Research GmbH0 个研究点目标入组 800 人开始时间: 2023年8月11日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
Female

入选标准

  • Patients =18 years undergoing cytoreductive surgery for endometrial cancer between 01/2011 and 12/2020 with the following criteria:
  • - Primary diagnosis of advanced endometrial cancer and peritoneal metastases (FIGO IV) undergoing cytoreductive surgery
  • - Diagnosis of recurrent endometrial cancer undergoing cytoreductive surgery Optional but strongly encouraged for translational part:
  • availability of FFPE tumor material from cytoreductive surgery

排除标准

  • 1. Patients with past medical history interfering with radical cytoreductive surgery
  • 2. Patients undergoing surgery solely for palliative intent
  • 3. Patients with secondary

研究者

相似试验